Literature DB >> 21310272

Compound heterozygous loss of Ext1 and Ext2 is sufficient for formation of multiple exostoses in mouse ribs and long bones.

Beverly M Zak1, Manuela Schuksz, Eiki Koyama, Christina Mundy, Dan E Wells, Yu Yamaguchi, Maurizio Pacifici, Jeffrey D Esko.   

Abstract

Multiple Hereditary Exostoses (MHE) syndrome is caused by haploinsufficiency in Golgi-associated heparan sulfate polymerases EXT1 or EXT2 and is characterized by formation of exostoses next to growing long bones and other skeletal elements. Recent mouse studies have indicated that formation of stereotypic exostoses requires a complete loss of Ext expression, suggesting that a similar local loss of EXT function may underlie exostosis formation in patients. To further test this possibility and gain greater insights into pathogenic mechanisms, we created heterozygous Ext1(+/-) and compound Ext1(+/-)/Ext2(+/-) mice. Like Ext2(+/-) mice described previously (Stickens et al. Development 132:5055), Ext1(+/-) mice displayed rib-associated exostosis-like outgrowths only. However, compound heterozygous mice had nearly twice as many outgrowths and, more importantly, displayed stereotypic growth plate-like exostoses along their long bones. Ext1(+/-)Ext2(+/-) exostoses contained very low levels of immuno-detectable heparan sulfate, and Ext1(+/-)Ext2(+/-) chondrocytes, endothelial cells and fibroblasts in vitro produced shortened heparan sulfate chains compared to controls and responded less vigorously to exogenous factors such as FGF-18. We also found that rib outgrowths formed in Ext1(f/+)Col2Cre and Ext1(f/+)Dermo1Cre mice, suggesting that ectopic skeletal tissue can be induced by conditional Ext ablation in local chondrogenic and/or perichondrial cells. The study indicates that formation of stereotypic exostoses requires a significant, but not complete, loss of Ext expression and that exostosis incidence and phenotype are intimately sensitive to, and inversely related to, Ext expression. The data also indicate that the nature and organization of ectopic tissue may be influenced by site-specific anatomical cues and mechanisms.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21310272      PMCID: PMC3335264          DOI: 10.1016/j.bone.2011.02.001

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  55 in total

1.  The effect of growth factors and synovial fluid on chondrogenesis in perichondrium.

Authors:  V Skoog; B Widenfalk; L Ohlsén; A Wasteson
Journal:  Scand J Plast Reconstr Surg Hand Surg       Date:  1990

2.  The natural history of hereditary multiple exostoses.

Authors:  G A Schmale; E U Conrad; W H Raskind
Journal:  J Bone Joint Surg Am       Date:  1994-07       Impact factor: 5.284

3.  Osteochondroma induced by reflection of the perichondrial ring in young rat radii.

Authors:  E Delgado; J I Rodríguez; J L Rodríguez; C Miralles; R Paniagua
Journal:  Calcif Tissue Int       Date:  1987-02       Impact factor: 4.333

4.  Biosynthesis of heparin/heparan sulfate. Identification of a 70-kDa protein catalyzing both the D-glucuronosyl- and the N-acetyl-D-glucosaminyltransferase reactions.

Authors:  T Lind; U Lindahl; K Lidholt
Journal:  J Biol Chem       Date:  1993-10-05       Impact factor: 5.157

5.  Biosynthesis of heparan sulfate on beta-D-xylosides depends on aglycone structure.

Authors:  T A Fritz; F N Lugemwa; A K Sarkar; J D Esko
Journal:  J Biol Chem       Date:  1994-01-07       Impact factor: 5.157

6.  Abrogation of heparan sulfate synthesis in Drosophila disrupts the Wingless, Hedgehog and Decapentaplegic signaling pathways.

Authors:  Douglas J Bornemann; Jason E Duncan; William Staatz; Scott Selleck; Rahul Warrior
Journal:  Development       Date:  2004-03-31       Impact factor: 6.868

7.  Ext1-dependent heparan sulfate regulates the range of Ihh signaling during endochondral ossification.

Authors:  Lydia Koziel; Melanie Kunath; Olivia G Kelly; Andrea Vortkamp
Journal:  Dev Cell       Date:  2004-06       Impact factor: 12.270

8.  Undersulfated heparan sulfate in a Chinese hamster ovary cell mutant defective in heparan sulfate N-sulfotransferase.

Authors:  K J Bame; J D Esko
Journal:  J Biol Chem       Date:  1989-05-15       Impact factor: 5.157

9.  Embryonic fibroblasts with a gene trap mutation in Ext1 produce short heparan sulfate chains.

Authors:  Shuhei Yamada; Marta Busse; Momoyo Ueno; Olivia G Kelly; William C Skarnes; Kazuyuki Sugahara; Marion Kusche-Gullberg
Journal:  J Biol Chem       Date:  2004-05-25       Impact factor: 5.157

10.  Developmental changes in heparan sulfate expression: in situ detection with mAbs.

Authors:  G David; X M Bai; B Van der Schueren; J J Cassiman; H Van den Berghe
Journal:  J Cell Biol       Date:  1992-11       Impact factor: 10.539

View more
  35 in total

1.  Epiphyseal abnormalities, trabecular bone loss and articular chondrocyte hypertrophy develop in the long bones of postnatal Ext1-deficient mice.

Authors:  Federica Sgariglia; Maria Elena Candela; Julianne Huegel; Olena Jacenko; Eiki Koyama; Yu Yamaguchi; Maurizio Pacifici; Motomi Enomoto-Iwamoto
Journal:  Bone       Date:  2013-08-17       Impact factor: 4.398

2.  Heparan sulfate antagonism alters bone morphogenetic protein signaling and receptor dynamics, suggesting a mechanism in hereditary multiple exostoses.

Authors:  Christina Mundy; Evan Yang; Hajime Takano; Paul C Billings; Maurizio Pacifici
Journal:  J Biol Chem       Date:  2018-04-05       Impact factor: 5.157

Review 3.  Interactions of signaling proteins, growth factors and other proteins with heparan sulfate: mechanisms and mysteries.

Authors:  Paul C Billings; Maurizio Pacifici
Journal:  Connect Tissue Res       Date:  2015       Impact factor: 3.417

Review 4.  Hereditary Multiple Exostoses: a review of clinical appearance and metabolic pattern.

Authors:  Giovanni Beltrami; Gabriele Ristori; Guido Scoccianti; Angela Tamburini; Rodolfo Capanna
Journal:  Clin Cases Miner Bone Metab       Date:  2016-10-05

Review 5.  The pathogenic roles of heparan sulfate deficiency in hereditary multiple exostoses.

Authors:  Maurizio Pacifici
Journal:  Matrix Biol       Date:  2017-12-24       Impact factor: 11.583

6.  Palovarotene Inhibits Osteochondroma Formation in a Mouse Model of Multiple Hereditary Exostoses.

Authors:  Toshihiro Inubushi; Isabelle Lemire; Fumitoshi Irie; Yu Yamaguchi
Journal:  J Bone Miner Res       Date:  2017-11-30       Impact factor: 6.741

7.  Loss of β-catenin induces multifocal periosteal chondroma-like masses in mice.

Authors:  Leslie Cantley; Cheri Saunders; Marta Guttenberg; Maria Elena Candela; Yoichi Ohta; Rika Yasuhara; Naoki Kondo; Federica Sgariglia; Shuji Asai; Xianrong Zhang; Ling Qin; Jacqueline T Hecht; Di Chen; Masato Yamamoto; Satoru Toyosawa; John P Dormans; Jeffrey D Esko; Yu Yamaguchi; Masahiro Iwamoto; Maurizio Pacifici; Motomi Enomoto-Iwamoto
Journal:  Am J Pathol       Date:  2012-12-25       Impact factor: 4.307

8.  An orthotopic mouse model for chondrosarcoma of bone provides an in vivo tool for drug testing.

Authors:  Jolieke G van Oosterwijk; Jacqueline R M Plass; Danielle Meijer; Ivo Que; Marcel Karperien; Judith V M G Bovée
Journal:  Virchows Arch       Date:  2014-10-21       Impact factor: 4.064

9.  Perichondrium phenotype and border function are regulated by Ext1 and heparan sulfate in developing long bones: a mechanism likely deranged in Hereditary Multiple Exostoses.

Authors:  Julianne Huegel; Christina Mundy; Federica Sgariglia; Patrik Nygren; Paul C Billings; Yu Yamaguchi; Eiki Koyama; Maurizio Pacifici
Journal:  Dev Biol       Date:  2013-03-01       Impact factor: 3.582

10.  Assessing the general population frequency of rare coding variants in the EXT1 and EXT2 genes previously implicated in hereditary multiple exostoses.

Authors:  Diana L Cousminer; Alexandre Arkader; Benjamin F Voight; Maurizio Pacifici; Struan F A Grant
Journal:  Bone       Date:  2016-09-09       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.